GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...
As anti-vaccine sentiment becomes more mainstream than ever, it’s hard to imagine most states successfully revoking vaccine ...
Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...
Zacks Investment Research on MSN
Here's Why GSK (GSK) is a Strong Growth Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
Introduction Although there are some drugs to control Parkinson’s disease (PD), they have several side effects and cannot ...
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that it will be presenting new data highlighting insights on patient outcomes with rozanolixizumab and zilucoplan for ...
Central skull base osteomyelitis is a rare, life-threatening condition that can present with vague symptoms and may be missed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback